The end of the trading week likely can't come fast enough for Vanda Pharmaceuticals ( VNDA -6.06%). The commercial-stage ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.

With a market capitalization of just $1.9 billion, Recursion still provides a potentially good entry point for investors, but that's only if there are good reasons to think that its strategy will pan ...

Mankind's strong execution capabilities and robust brand equity align well with Bharat Serums and Vaccines' super-specialty ...

The good news is that if you're willing to put in a bit of effort, it's very possible to improve on your process to secure ...

We recently compiled a list of the 10 Largest Biotech Hedge Funds and Their Top Stock Picks. In this article, we are going to ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

In this piece, we will take a look at the 10 largest biotech hedge funds and their top stock picks. The ability to ...

Indian shares are set to open higher on Tuesday, tracking a rebound in global stocks ahead of the key U.S. inflation data and ...

Shares of Vertex Pharmaceuticals Inc. VRTX inched 0.84% higher to $474.74 Wednesday, on what proved to be an all-around ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the ...